rts logo

Evolent Health Inc (EVH) Stock Could Soon Reward Patient Investors

Evolent Health Inc (NYSE: EVH) is -16.11% lower on its value in year-to-date trading and has touched a low of $17.98 and a high of $35.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EVH stock was last observed hovering at around $27.38 in the last trading session, with the day’s gains setting it 0.33%.

Currently trading at $27.71, the stock is 18.85% and 26.59% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.31 million and changing 1.21% at the moment leaves the stock 0.39% off its SMA200. EVH registered 6.17% gain for a year compared to 6-month loss of -10.47%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a 40.73% gain in the last 1 month and extending the period to 3 months gives it a 20.11%, and is 9.57% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.02% over the week and 5.79% over the month.

Evolent Health Inc (EVH) has around 4700 employees, a market worth around $3.22B and $2.35B in sales. Fwd P/E is 17.93. Profit margin for the company is -4.51%. Distance from 52-week low is 54.12% and -20.83% from its 52-week high. The company has generated returns on investments over the last 12 months (-5.69%).

with sales reaching $628.26M over the same period.The EPS is expected to grow by 20.74% this year, but quarterly earnings will post 31.30% year-over-year. Quarterly sales are estimated to grow 23.40% in year-over-year returns.

Evolent Health Inc (EVH) Top Institutional Holders

346.0 institutions hold shares in Evolent Health Inc (EVH), with institutional investors hold 120.66% of the company’s shares. The shares outstanding are 113.89M, and float is at 110.55M with Short Float at 12.97%. Institutions hold 115.80% of the Float.

The top institutional shareholder in the company is VANGUARD GROUP INC with over 10.92 million shares valued at $$357.91 million. The investor’s holdings represent 9.5628 of the EVH Shares outstanding. As of 2024-03-31, the second largest holder is FMR LLC with 10.59 million shares valued at $$347.32 million to account for 9.28 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 8.85 million shares representing 7.7567 and valued at over $$290.31 million, while BLACKROCK INC. holds 7.2677 of the shares totaling 8.3 million with a market value of $$272.01 million.

Evolent Health Inc (EVH) Insider Activity

The most recent transaction is an insider sale by Blackley Seth,the company’sChief Executive Officer. SEC filings show that Blackley Seth sold 141,000 shares of the company’s common stock on Dec 05 ’23 at a price of $26.54 per share for a total of $3.74 million. Following the sale, the insider now owns 0.64 million shares.

Evolent Health Inc disclosed in a document filed with the SEC on Nov 15 ’23 that McCarthy Daniel Joseph (PRESIDENT) sold a total of 11,000 shares of the company’s common stock. The trade occurred on Nov 15 ’23 and was made at $30.00 per share for $0.33 million. Following the transaction, the insider now directly holds 0.2 million shares of the EVH stock.

Related Posts